David C. Johnson
51 works · 2,148 citations · h-index 17
Top works
- Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma
- A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value
- Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
- Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma
- Homozygous Deletion Mapping in Myeloma Samples Identifies Genes and an Expression Signature Relevant to Pathogenesis and Outcome
- Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
- Herpesvirus Evasion of the Immune System
- XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments
- Inherited genetic susceptibility to multiple myeloma
- Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
- Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression
- Improved risk stratification in myeloma using a micro RNA ‐based classifier
- MMSET is the key molecular target in t(4;14) myeloma
- Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma
- Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
- Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci
- Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma
- Genetic factors influencing the risk of multiple myeloma bone disease
- Genetic Variation in ADME Genes Is Associated with Thalidomide Related Peripheral Neuropathy in Multiple Myeloma Patients.
- Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism